Bill

Bill > SB1718


TN SB1718

As introduced, caps the total amount that a health insurance carrier can require a covered patient with diabetes to pay for a 30-day supply of insulin at no more than $100; requires the department of health and the division of consumer affairs to study and investigate the pricing of prescription insulin drugs and report findings no later than November 1, 2020. - Amends TCA Title 8; Title 53; Title 56, Chapter 7; Title 63; Title 68 and Title 71, Chapter 5.


summary

Introduced
01/16/2020
In Committee
Crossed Over
Passed
Dead
06/19/2020

Introduced Session

111th General Assembly

Bill Summary

As introduced, caps the total amount that a health insurance carrier can require a covered patient with diabetes to pay for a 30-day supply of insulin at no more than $100; requires the department of health and the division of consumer affairs to study and investigate the pricing of prescription insulin drugs and report findings no later than November 1, 2020. - Amends TCA Title 8; Title 53; Title 56, Chapter 7; Title 63; Title 68 and Title 71, Chapter 5.

AI Summary

This bill caps the total amount that a health insurance carrier can require a covered patient with diabetes to pay for a 30-day supply of insulin at no more than $100. It also requires the Department of Health and the Division of Consumer Affairs to study and investigate the pricing of prescription insulin drugs and report their findings by November 1, 2020. The bill amends various sections of Tennessee's legal code, including Title 8, Title 53, Title 56 Chapter 7, Title 63, Title 68, and Title 71 Chapter 5.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Action deferred in Senate Commerce & Labor Committee (on 03/17/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...